2120 - Manufacture of pharmaceutical preparations
Net Revenue (M€): 20.0 M€ EBITDA (M€): 3.0 M€ Number of Employees: 20
Internationally recognized pharmaceutical company. Specialist distribution of medicines and equipment for medical supplies. Production of high-quality nutritional supplements. Very large growth potential.
Listed by M&A World Business Support Center on Monday, 20 March 2023 [Seller (Sell-side)] - Ref.: PHARMA
3 Hits
Net Revenue (M€): 100.0 M€ EBITDA (M€): Request Information
The buyer is a chemical manufacturer and distributor, active in cosmetics manufacturing and development, trading and distribution of thinners, binders and additives for the paint, coatings and adhesives industry. The customers of the company include the largest global companies and sellers of cosmetics and similar production.
Listed by M&A World Business Support Center on Wednesday, 31 January 2018 [Investor (Buy-side)] - Ref.: 937
1130 Hits
Net Revenue (M€): 700.0 M€ EBITDA (M€): 130.0 M€
The Investor company is an innovative chemicals and aroma manufacturing firm with global presence. The aroma manufacturing division of the buyer specializes mainly in three segments: Bakery, Chocolate, Confectionery.
Listed by M&A World Business Support Center on Wednesday, 31 January 2018 [Investor (Buy-side)] - Ref.: 934
899 Hits
Net Revenue (M€): 3.0 M€ EBITDA (M€): 1.0 M€
The Investor is a pharmaceutical manufacturer with a wide portfolio of products (over 150 brands). They are delievering to both domestic and international markets. The buyer's manufacturing units are certified by the needed requirements.
Listed by M&A World Business Support Center on Wednesday, 31 January 2018 [Investor (Buy-side)] - Ref.: 927
953 Hits
Net Revenue (M€): 10.0 M€ EBITDA (M€): Request Information
Investor operates in the pharmaceutical industry is seeking businesses open for sale. The European Company is one of the leader in the pharmaceutical industry in Europe.
Listed by M&A World Business Support Center on Tuesday, 18 July 2017 [Investor (Buy-side)] - Ref.: 633
3038 Hits
Net Revenue (M€): 3.0 M€ EBITDA (M€): Request Information
Veterinary industrial investor is seeking businesses open for sale
Listed by M&A World Business Support Center on Monday, 17 July 2017 [Investor (Buy-side)] - Ref.: 592
3041 Hits
Net Revenue (M€): 5.0 M€ EBITDA (M€): Request Information
The Investor is seeking pharmaceutical products manufacturer in Europe
Listed by M&A World Business Support Center on Monday, 10 July 2017 [Investor (Buy-side)] - Ref.: 583
2818 Hits
Net Revenue (M€): 24.0 M€ EBITDA (M€): 3.0 M€ Number of Employees: 700
The group was established in the 90 s with the registered office in China and is now developing into a leading pharmaceutical company in Asia with vertically integrated intermediates and formulations based on R & D manufacture and sales. As an innovative and dynamic group in pharmaceuticals the products mainly involve in Psychotropic Cardiovascular Antithrombotic Antitumor Gastrointestinal Anti-infection(antivirotic) and Veterinary. The Company s market covers Asia Europe Africa South Am
Listed by M&A World Business Support Center on Friday, 03 March 2017 [Seller (Sell-side)] - Ref.: 62
4467 Hits
Net Revenue (M€): 36.0 M€ EBITDA (M€): 15.0 M€ Number of Employees: 50
Family owned business with more than 100 years, strong track record and expansion plans in progress. The shareholders are considering divesting its stake in the company sincethere isa successionlack. The laboratory employs over 330 employees and more than 30 sales representatives working throughout the Brazilian territory. Although the company produces only medicine, It is authorized to manufacture medicines, cosmetics, perfumes and toiletries.
There are 31 medication records at ANVISA, among
Listed by Elit Capital on Friday, 03 March 2017 [Seller (Sell-side)] - Ref.: 20
4832 Hits
Net Revenue (M€): 70.0 M€ EBITDA (M€): 8.0 M€ Number of Employees: 35
The Company is a privately owned and funded holding operated as family office. It is seeking engagement in owner driven companies in order to assist and help be a sparring partner advisor financier and even take over leadership and all aspects of getting family businesses handed over to the next generation.
Listed by M&A World Business Support Center on Wednesday, 01 March 2017 [Investor (Buy-side)] - Ref.: 600
4807 Hits